🔎 Trials Near Me

Hem › Steatotisk leversjukdom › Texas › Austin

Kliniska studier för Steatotisk leversjukdom i Austin, TX

13 studier för Steatotisk leversjukdom söker deltagare vid platser i och runt Austin (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

RekryterarFas 3
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
Ålder 18 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

RekryterarFas 3
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
Ålder 18 till 80 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06318169

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

RekryterarFas 2
  • American Research Corporation, Austin
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

RekryterarFas 2
  • American Research Corporation, Austin
  • Pinnacle Clinical Research - Austin, Austin
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

RekryterarFas 3
  • IMA Clinical Research Austin, Austin
  • American Research Corporation, Austin
  • Pinnacle Clinical Research, Austin
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

RekryterarFas 3
  • Akero Clinical Study Site, Austin
  • Akero Clinical Study Site, Austin
  • Akero Clinical Study Site, Austin
Ålder 18 till 80 · Alla kön · Uppdaterad 21 sep. 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

RekryterarFas 3
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
Ålder 18 till 75 · Alla kön · Uppdaterad 17 sep. 2026 · NCT07221188

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

RekryterarFas 2
  • GSK Investigational Site, Austin
Ålder 18 till 70 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

RekryterarFas 3
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
Ålder 18 till 75 · Alla kön · Uppdaterad 27 juli 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

RekryterarFas 2
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
Ålder 18 till 75 · Alla kön · Uppdaterad 8 juli 2026 · NCT06920043

Steatotisk leversjukdom-studier i andra städer

Andra studier i Austin

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.